Medpace Holdings Statistics

Total Valuation

BMV:MEDP has a market cap or net worth of MXN 169.23 billion. The enterprise value is 163.73 billion.

Market Cap	169.23B
Enterprise Value	163.73B

Important Dates

The next estimated earnings date is Monday, July 21, 2025.

Earnings Date	Jul 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	28.74M
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-2.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	22.54M

Valuation Ratios

The trailing PE ratio is 19.89 and the forward PE ratio is 24.11.

PE Ratio	19.89
Forward PE	24.11
PS Ratio	3.84
PB Ratio	13.95
P/TBV Ratio	n/a
P/FCF Ratio	15.31
P/OCF Ratio	14.23
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.35, with an EV/FCF ratio of 14.81.

EV / Earnings	19.24
EV / Sales	4.01
EV / EBITDA	16.35
EV / EBIT	18.96
EV / FCF	14.81

Financial Position

The company has a current ratio of 0.73, with a Debt / Equity ratio of 0.25.

Current Ratio	0.73
Quick Ratio	0.66
Debt / Equity	0.25
Debt / EBITDA	0.28
Debt / FCF	0.28
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 65.82% and return on invested capital (ROIC) is 36.25%.

Return on Equity (ROE)	65.82%
Return on Assets (ROA)	15.44%
Return on Invested Capital (ROIC)	36.25%
Return on Capital Employed (ROCE)	58.88%
Revenue Per Employee	7.47M
Profits Per Employee	1.44M
Employee Count	5,900
Asset Turnover	1.17
Inventory Turnover	n/a

Taxes

In the past 12 months, BMV:MEDP has paid 1.33 billion in taxes.

Income Tax	1.33B
Effective Tax Rate	13.49%

Stock Price Statistics

The stock price has decreased by -12.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-12.20%
50-Day Moving Average	4,302.85
200-Day Moving Average	n/a
Relative Strength Index (RSI)	56.43
Average Volume (20 Days)	323

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	6.11

Income Statement

In the last 12 months, BMV:MEDP had revenue of MXN 44.08 billion and earned 8.51 billion in profits. Earnings per share was 267.54.

Revenue	44.08B
Gross Profit	30.01B
Operating Income	9.33B
Pretax Income	9.84B
Net Income	8.51B
EBITDA	9.92B
EBIT	9.33B
Earnings Per Share (EPS)	267.54

Full Income Statement

Balance Sheet

The company has 9.02 billion in cash and 3.07 billion in debt, giving a net cash position of 5.95 billion.

Cash & Cash Equivalents	9.02B
Total Debt	3.07B
Net Cash	5.95B
Net Cash Per Share	n/a
Equity (Book Value)	12.13B
Book Value Per Share	407.60
Working Capital	-6.15B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.89 billion and capital expenditures -838.91 million, giving a free cash flow of 11.06 billion.

Operating Cash Flow	11.89B
Capital Expenditures	-838.91M
Free Cash Flow	11.06B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 68.08%, with operating and profit margins of 21.16% and 19.31%.

Gross Margin	68.08%
Operating Margin	21.16%
Pretax Margin	22.32%
Profit Margin	19.31%
EBITDA Margin	22.51%
EBIT Margin	21.16%
FCF Margin	25.08%

Dividends & Yields

BMV:MEDP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.03%
Shareholder Yield	n/a
Earnings Yield	5.03%
FCF Yield	6.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:MEDP has an Altman Z-Score of 6.7 and a Piotroski F-Score of 5.

Altman Z-Score	6.7
Piotroski F-Score	5